Below are the top biotechnology stocks on the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at
PDL BioPharma, Inc. (NASDAQ:
PDLI) is 94.00%. PDL BioPharma's PEG ratio is 0.28.
The trailing-twelve-month operating margin at
Enzon Pharmaceuticals Inc. (NASDAQ:
ENZN) is 92.30%. Enzon Pharmaceuticals' EPS for the same period is $0.65.
The trailing-twelve-month operating margin at
Enanta Pharmaceuticals, Inc. (NASDAQ:
ENTA) is 76.20%. Enanta Pharmaceuticals' revenue for the same period is $124.30 million.
The trailing-twelve-month operating margin at
NewLink Genetics Corporation (NASDAQ:
NLNK) is 68.10%. NewLink Genetics' EPS growth forecast for the next year is 4.40%.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
